FDA Inspection 1081947 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on February 13, 2019 in Scranton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 13, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Scranton, PA (United States)